Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Compugen Ltd (CGEN)

4 -0.2 (-4.76%)

04-20 16:00

Open:

4.25

Pre. Close:

4.2

High:

4.25

Low:

3.95

Volume:

171,908

Market Cap:

207M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

4.258 - 4.282

4.282 - 4.309

Low:

3.885 - 3.911

3.911 - 3.939

Close:

3.952 - 3.996

3.996 - 4.045

Technical analysis  (as of: 2018-04-20 4:28:17 PM)

Overall:

      

Stoxline posted a SELL today, same as yesterday. This stock seems to continue bearish move. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell now, downward move is expected.

Target:

Six months: 5.22     One year: 5.84

Support:

Support1: 3.60    Support2: 3.00

Resistance:

Resistance1: 4.47    Resistance2: 5.00

Pivot:

4.37

Moving Averages:

MA(5): 4.22     MA(20): 4.30

MA(100): 3.33     MA(250): 3.51

MACD:

MACD(12,26): 0.07     Signal(12,26,9): 0.14

%K %D:

%K(14,3): 21.29     %D(3): 33.44

RSI:

RSI(14): 43.05

52-Week:

High: 5.4  Low: 2.25  Change(%):

Average Vol(K):

3-Month: 31625  10-Days 18358

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
CGEN has closed below the lower band by 6.5%. If price is in a downtrend band; this downward trend in price might continue. However a short term pullback inside the band is likely. Bollinger Bands are 18% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

2018-04-17T09:49:41-04:00
Bayer's ILDR2 inhibitor shows encouraging action in preclinical studies, discoverer Compugen up 4%

2018-04-17T07:00:00-04:00
Preclinical Data Presented by Bayer at AACR Highlights BAY 1905254, Formerly the CGEN-15001T Program, Efficacy in Cancer Immunotherapy

2018-04-05T14:03:03-04:00
Compugen's (CGEN) CEO Anat Cohen-Dayag on MedImmune License Agreement Call (Transcript)

2018-04-03T11:48:30-04:00
Your Daily Pharma Scoop: MediciNova Makes A Strong Comeback, Alkermes' Setback, BioLife Preliminary Q1 Results

2018-04-02T09:14:22-04:00
Premarket Gainers as of 9:05 am (04/02/2018)

2018-04-02T07:54:47-04:00
Compugen inks antibody development deal with AstraZeneca; shares ahead 11% premarket

2018-04-02T07:25:00-04:00
Compugen Announces Exclusive License Agreement With MedImmune for the Development of Bi-Specific and Multi-Specific Antibody Products

2018-03-29T08:52:34-04:00
Premarket analyst action - healthcare

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Biotechnology Medical Research

Shares Out. (M)

51.29

Shares Float (M)

51.29

% Held by Insiders

% Held by Institutions

12.90

Shares Short (K)

2977

Shares Short Prior Month (K)

1730

Stock Financials

EPS

-0.720

EPS Est. Current Year

-0.730

EPS Est. Next Year

-0.830

EPS Est. Next Quarter

-0.190

Forward EPS

-0.809

Book Value (p.s.)

7.880

PEG Ratio

Profit Margin

Operating Margin

Return on Assets (ttm)

-67.5

Return on Equity (ttm)

-79.9

Qtrly Rev. Growth

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

-0.546

Qtrly Earnings Growth

Operating Cash Flow (M)

-30.66

Levered Free Cash Flow (M)

-17.73

atoplab.com

Valuation

P/E

-5.56

P/E Growth Ratio

-0.05

P/BV

0.51

P/S

P/CF

-6.69

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.